LivaNova PLC (NASDAQ:LIVN) Receives Consensus Recommendation of “Buy” from Brokerages

Shares of LivaNova PLC (NASDAQ:LIVN) have earned a consensus rating of “Buy” from the seven research firms that are covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month target price among analysts that have covered the stock in the last year is $69.17.

A number of analysts recently commented on the stock. Robert W. Baird boosted their target price on shares of LivaNova from $66.00 to $72.00 and gave the stock an “outperform” rating in a report on Thursday, October 31st. Needham & Company LLC reaffirmed a “buy” rating and issued a $75.00 price target on shares of LivaNova in a report on Tuesday, January 28th. Mizuho cut their price objective on LivaNova from $80.00 to $70.00 and set an “outperform” rating for the company in a research report on Thursday, October 31st. Finally, StockNews.com upgraded LivaNova from a “buy” rating to a “strong-buy” rating in a report on Friday.

Insider Buying and Selling at LivaNova

In other LivaNova news, Director Francesco Bianchi sold 1,250 shares of LivaNova stock in a transaction dated Wednesday, December 11th. The stock was sold at an average price of $50.99, for a total transaction of $63,737.50. Following the transaction, the director now owns 7,522 shares of the company’s stock, valued at $383,546.78. The trade was a 14.25 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Company insiders own 0.27% of the company’s stock.

Institutional Trading of LivaNova

A number of hedge funds have recently made changes to their positions in LIVN. Russell Investments Group Ltd. increased its stake in LivaNova by 17.1% in the 4th quarter. Russell Investments Group Ltd. now owns 1,502 shares of the company’s stock valued at $70,000 after buying an additional 219 shares during the period. Sterling Capital Management LLC increased its stake in shares of LivaNova by 800.6% in the fourth quarter. Sterling Capital Management LLC now owns 1,621 shares of the company’s stock worth $75,000 after acquiring an additional 1,441 shares during the last quarter. Central Pacific Bank Trust Division raised its holdings in shares of LivaNova by 21.2% during the fourth quarter. Central Pacific Bank Trust Division now owns 4,117 shares of the company’s stock worth $191,000 after acquiring an additional 720 shares in the last quarter. Vestcor Inc acquired a new stake in LivaNova during the fourth quarter valued at $204,000. Finally, Optimize Financial Inc purchased a new position in LivaNova in the fourth quarter valued at about $208,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

LivaNova Stock Performance

Shares of LIVN stock opened at $47.68 on Friday. LivaNova has a 52 week low of $43.15 and a 52 week high of $64.47. The company has a current ratio of 3.37, a quick ratio of 2.87 and a debt-to-equity ratio of 0.46. The company has a market cap of $2.59 billion, a PE ratio of 113.52 and a beta of 1.00. The company’s fifty day simple moving average is $48.30 and its 200-day simple moving average is $49.56.

LivaNova Company Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.